CVR number 63717916
Industry 21.2000 Manufacture of pharmaceutical preparations

ALK-ABELLÓ A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmarkIFRS
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 1.6% 2.1% 4.6% 1.6%  
Credit score (0-100)  0 77 70 48 77  
Credit rating  N/A A A BBB A  
Credit limit (mDKK)  0.0 4.5 0.2 0.0 4.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 961 1,088 925 856  
Gross profit  0.0 389 271 196 109  
EBITDA  0.0 -329 -452 -1,087 -642  
EBIT  0.0 -329 -452 -1,087 -642  
Pre-tax profit (PTP)  0.0 -277.0 -509.0 -999.0 178.0  
Net earnings  0.0 -210.0 -391.0 -772.0 307.0  
Pre-tax profit without non-rec. items  0.0 -277 -509 -999 178  
 
See the entire income statement

Balance sheet (mDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Tangible assets total  0.0 769 699 681 712  
Shareholders equity total  0.0 2,119 2,386 1,624 1,938  
Interest-bearing liabilities  0.0 1,840 1,995 2,264 1,502  
Balance sheet total (assets)  0.0 4,640 5,073 4,583 4,493  
Net Debt  0.0 1,753 1,937 2,134 1,314  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 961 1,088 925 856  
Net sales growth  0.0% 0.0% 13.2% -15.0% -7.5%  
Gross profit  0.0 389 271 196 109  
Gross profit growth  0.0% 0.0% -30.3% -27.7% -44.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 4,640 5,073 4,583 4,493  
Balance sheet change%  0.0% 0.0% 9.3% -9.7% -2.0%  
Added value  0.0 -329.0 -452.0 -1,087.0 -642.0  
Added value %  0.0% -34.2% -41.5% -117.5% -75.0%  
Investments  0 1,686 -177 -690 30  
Net sales trend  0.0 0.0 1.0 -1.0 -2.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
EBITDA %  0.0% -34.2% -41.5% -117.5% -75.0%  
EBIT %  0.0% -34.2% -41.5% -117.5% -75.0%  
EBIT to gross profit (%)  0.0% -84.6% -166.8% -554.6% -589.0%  
Net Earnings %  0.0% -21.9% -35.9% -83.5% 35.9%  
Profit before depreciation and extraordinary items %  0.0% -21.9% -35.9% -83.5% 35.9%  
Pre tax profit less extraordinaries %  0.0% -28.8% -46.8% -108.0% 20.8%  
ROA %  0.0% -5.7% -8.1% -20.1% 4.6%  
ROI %  0.0% -6.0% -8.5% -21.2% 5.0%  
ROE %  0.0% -9.9% -17.4% -38.5% 17.2%  

Solidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 45.7% 47.0% 35.4% 43.1%  
Relative indebtedness %  0.0% 262.3% 247.0% 319.9% 298.5%  
Relative net indebtedness %  0.0% 253.3% 241.6% 305.8% 276.5%  
Net int. bear. debt to EBITDA, %  0.0% -532.8% -428.5% -196.3% -204.7%  
Gearing %  0.0% 86.8% 83.6% 139.4% 77.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 1.3% 6.2% 1.3% 1.8%  

Liquidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Quick Ratio  0.0 0.5 0.6 0.4 0.6  
Current Ratio  0.0 0.7 0.8 0.5 0.8  
Cash and cash equivalent  0.0 87.0 58.0 130.0 188.0  

Capital use efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 0.8 1.3 0.8 2.1  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 126.5% 146.1% 125.5% 154.6%  
Net working capital  0.0 -549.0 -357.0 -1,074.0 -268.0  
Net working capital %  0.0% -57.1% -32.8% -116.1% -31.3%  

Employee efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0